WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niemann, S.
Right arrow Articles by Nave, K.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niemann, S.
Right arrow Articles by Nave, K.-A.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

Uncoupling of Myelin Assembly and Schwann Cell Differentiation by Transgenic Overexpression of Peripheral Myelin Protein 22

Stephan Niemann1, Michael W. Sereda1, Ueli Suter2, Ian R. Griffiths3, and Klaus-Armin Nave1

1 Zentrum für Molekulare Biologie (ZMBH), University of Heidelberg, D-69120 Heidelberg, Germany, 2 Institute of Cell Biology, Department of Biology, Swiss Federal Institute of Technology, Eidgenössische Technische Hochschule-Hoenggerberg, CH-8093 Zürich, Switzerland, and 3 Applied Neurobiology Group, Department of Veterinary Clinical Studies, University of Glasgow, Glasgow G61 1QH, United Kingdom

We have generated previously transgenic rats that overexpress peripheral myelin protein 22 (PMP22) in Schwann cells. In the nerves of these animals, Schwann cells have segregated with axons to the normal 1:1 ratio but remain arrested at the promyelinating stage, apparently unable to elaborate myelin sheaths. We have examined gene expression of these dysmyelinating Schwann cells using semiquantitative reverse transcription-PCR and immunofluorescence analysis. Unexpectedly, Schwann cell differentiation appears to proceed normally at the molecular level when monitored by the expression of mRNAs encoding major structural proteins of myelin. Furthermore, an aberrant coexpression of early and late Schwann cell markers was observed. PMP22 itself acquires complex glycosylation, suggesting that trafficking of the myelin protein through the endoplasmic reticulum is not significantly impaired. We suggest that PMP22, when overexpressed, accumulates in a late Golgi-cell membrane compartment and uncouples myelin assembly from the underlying program of Schwann cell differentiation.

Key words: transgenic disease model; Charcot-Marie-Tooth neuropathy; myelin disease; axon-Schwann cell interaction; abnormal gene dosage; myelin protein function


Copyright © 2000 Society for Neuroscience  0270-6474/00/20114120-09$05.00/0


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Nobbio, L. Sturla, F. Fiorese, C. Usai, G. Basile, I. Moreschi, F. Benvenuto, E. Zocchi, A. De Flora, A. Schenone, et al.
P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A Neuropathy
J. Biol. Chem., August 21, 2009; 284(34): 23146 - 23158.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Chies, L. Nobbio, P. Edomi, A. Schenone, C. Schneider, and C. Brancolini
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22
J. Cell Sci., March 15, 2003; 116(6): 987 - 999.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Dickson, J. J. M. Bergeron, I. Shames, J. Colby, D. T. Nguyen, E. Chevet, D. Y. Thomas, and G. J. Snipes
Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for "gain-of-function" ER diseases
PNAS, July 23, 2002; 99(15): 9852 - 9857.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Sancho, P. Young, and U. Suter
Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A
Brain, November 1, 2001; 124(11): 2177 - 2187.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Perea, A. Robertson, T. Tolmachova, J. Muddle, R. H. M. King, S. Ponsford, P. K. Thomas, and C. Huxley
Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A
Hum. Mol. Genet., May 1, 2001; 10(10): 1007 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Schneider, F. Bosse, D. D'Urso, H.-W. Muller, M. W. Sereda, K.-A. Nave, A. Niehaus, T. Kempf, M. Schnolzer, and J. Trotter
The AN2 Protein Is a Novel Marker for the Schwann Cell Lineage Expressed by Immature and Nonmyelinating Schwann Cells
J. Neurosci., February 1, 2001; 21(3): 920 - 933.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-